NASA’s latest change in plans comes two weeks after the space agency said it was working “expeditiously” to bring back ...

FOR the first time, a deadly brain swelling disease has been detected in British patients with no travel history – which ...

Crossject (ISIN: FR0011716265; Euronext Growth : ALCJ), a specialty pharma company developing medicines harnessing its unique, award-winning needle-free ZENEO® auto-injector to deliver life-saving ...